Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 11781 - 11790 of 12702 results

First page
Previous page
Next page
Next page

VANILLA PLANIFOLIA OIL

0A3F415158

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2014)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0519bc2-558b-4633-b286-e888b800b1b9

First approved in 2007

Source:

21 CFR 356

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=675545a8-e2b3-428f-9d60-fd5419bdc97a

Class:

STRUCTURALLY DIVERSE

POMEGRANATE SEED

7294Z34NS7

Status:

Possibly Marketed Outside US

Source:

21 CFR 333D

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b265d88-1946-4647-b421-21b684d6e978

First approved in 2007

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d18b4c19-0365-44ec-bea8-4328e537e0d8

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

KAE6NLU69V

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

37H6EG2NAQ

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

U6C4GJ6WZG

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

8UK4958MZX

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

9A68J3T9TE

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

PEG-60 LANOLIN

K2OI1D27ET

Status:

Possibly Marketed Outside US

Source:

21 CFR 333A

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=007bcc58-e10e-4c8f-a537-dec23c89987e

First approved in 2007

Source:

21 CFR 333A

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=007bcc58-e10e-4c8f-a537-dec23c89987e

Class:

STRUCTURALLY DIVERSE

AMINO ACIDS, OAT

NU3FAK86IP

Status:

Possibly Marketed Outside US

Source:

21 CFR 356

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=675545a8-e2b3-428f-9d60-fd5419bdc97a

First approved in 2007

Source:

21 CFR 356

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=675545a8-e2b3-428f-9d60-fd5419bdc97a

Class:

STRUCTURALLY DIVERSE

CUCUMIS SATIVUS LEAF

Q6S42514LP

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2014)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0519bc2-558b-4633-b286-e888b800b1b9

First approved in 2007

Source:

21 CFR 358H

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aed1f641-b50f-3796-e053-2a95a90a47af

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

VANILLA PLANIFOLIA OIL

Structurally Diverse

POMEGRANATE SEED

Structurally Diverse

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

Structurally Diverse

AMINO ACIDS, OAT

Structurally Diverse

CUCUMIS SATIVUS LEAF

Showing 11781 - 11790 of 12702 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1